BUY Target Price: Rs 1,400



Similar documents
Khambatta Securities Ltd.

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

Axis Bank. Strong core performance. Source: Company Data; PL Research

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

Kotak Mahindra Bank Rs 685

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

Gujarat State Petronet Ltd. INR 135

Quant Picks United Breweries

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, Target Price Rs788

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

HCC BUY. Infrastructure January 29, 2016

Axis Bank INR 521. Target Price (INR): 600. Staunch operating metrics; but blemish asset quality. Potential Upside: 15.16%

ICICI BANK INR 233. Dismal asset quality performance. Target Price (INR): 314. India Equity Institutional Research BFSI.

Navin Fluorine International

GAIL (India) Ltd. INR 346

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

Company Overview. Financial Performance

The Ramco Cements. Source: Company Data; PL Research

Strong operational performance

Gladiator Stocks: Phillips Carbon Black (PHICAR) Time Frame: Six months

Federal Bank (FEDBAN) 50

Britannia Industries

State Bank of India. Source: Company Data; PL Research

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

GlaxoSmithKline Consumer Healthcare

Minda Industries Ltd. INR 886

Research Analysts. September 30, 2015

City Union Bank (CITUNI) 87

Research Analysts. June 30, Lupin LUPIN Buy in the range of

Flexituff International Ltd. (FIL)

Mangalam Cement Weak volumes marred performance

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

Greenply Industries Ltd

When the going get tough...

Simplex Infrastructures

Research Analysts. Granules GRANUL Buy in the range of EID Parry EIDPAR Buy in the range of

Pidilite Industries. Source: Company Data; PL Research

QATAR NATIONAL BANK (QE: QNBK)

Techno Electric & Engineering Limited

Company Report. New China Life (1336 HK) Hold Life & Health Insurance Industry 2013E target price: HK$34.30 (from HK$24.

Tree House Education & Accessories

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

Bata India Ltd. (BIL)

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

Private drilling fluid technology service leader

PTC India Financial Services (PTCIND) 42

KINDLY REFER TO THE LAST PAGE OF THIS PUBLICATION FOR IMPORTANT DISCLOSURES

Ituran Location & Control Ltd. In-line Quarter, Big Dividend, Maintain Outperform

Larsen & Toubro. Source: Company Data; PL Research

Results impacted by subdued demand

Derivatives Weekly DERIVATIES DESK. Outlook: Outlook: Sell in May and Go Away! DOLAT CAPITAL. Brief Outlook :

SBERBANK GROUP S IFRS RESULTS. March 2015

Merger of ING Vysya Bank with Kotak Mahindra Bank

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Shriram Transport Finance

MOSt Market Outlook 1st, July 2016

Jubilant Life Sciences

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

East India Hotels (EIH) 114

Credit Analysis and Research Ltd. CARE : SUBSC RIBE 4th December, Financial summary (Consolidated) - Rs. mn

How To Grow In Kotak Bank

Higher other income drive the quarter

Bright Smart (1428 HK)

Butterfly Gandhimathi (GANAP) 188

Results for the quarter ended December 31, Investor Presentation January 21, 2016

CENTRAL SECURITIES CLEARING SYSTEM PLC. CSCS: from West Africa to the rest of the world. Recommendation: BUY

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

Just Dial Ltd Bloomberg Code: JUST IN

Time to reap synergies

Company Report. Ping An (2318 HK) Sell Life & Health Insurance Industry 2013E target price: HK$68.46 (from HK$58.04 previously)

Emirates NBD (ENBD) Strong Buy. Target Price AED10.0. Global Research Investment Update Equity UAE Banking Sector 31 January, 2016

East India Hotels (EIH) 109

Merger of ING Vysya Bank with Kotak Mahindra Bank

Investment Rationale

Axis Bank BUY. More misses than hits. Results Review INDIA TP: INR % AXSB IN

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

2 nd Quarter, 2012 Results ANALYST MEETING, 27 JULY, 2012

UltraTech Cement Ltd.

Longfor (960 HK) Unrated Real Estate Development Industry

Techno Electric & Engineering Co Ltd

E 2013E 2014E

Transcription:

Consistent; gaining ground faster HDFC Bank (HDFCB) reported an in-line Q4FY16, with PAT of Rs 33.7bn (up 20% YoY) driven by robust 24% YoY growth in NII. Hallmark of earnings was 27% YoYgrowth in advances significantly above industry s growth rate (~11% YoY); the beat implies market share gain for HDFCB in both retail and corporate segments. NIM was resilient at 4.3% and asset qualitypristine. Our view: HDFCB s business growth will continue, and the bank will gain market share further. Expect CAGR loan growth at 24% over FY16-18. Foresee headwinds to margins from MCLR regime and increased competition, though impact would be marginal. Management is confident of maintaining margins in the range of 4.0-4.4%. 25 APR 2016 Quarterly Update BUY Target Price: Rs 1,400 CMP : Rs 1,092 Potential Upside : 28% MARKET DATA No. of Shares : 2,528mn Free Float : 74% Market Cap : Rs2,762bn 52-week High / Low : Rs1,128 / Rs929 Avg. Daily vol. (6mth) : 1.5 mn shares Bloomberg Code : HDFCB IB Equity Promoters Holding : 26% FII / DII : 32% / 14% Q4 key highlights: (a) Loan growth (+27%YoY) was propped up by both retail (+30%YoY) and wholesale (+27%YoY) loans; (b) spike in home loan portfolio was from HDFCB buying out 70% of loans originated for HDFC Ltd (vs 50% earlier); (c) LDRimproved to 85% (up ~160 bps QoQ),as deposit growth (+21%) lagged advances growth; (d) GNPA ratio improved slightly to 0.94% while NNPA ratio was flat QoQ; (e) ~Rs3bn of floating provisions were drawn down to provide against agri-credit facility lent to Punjab and a large corporate account;(f) non-interest income growth (+11.8% YoY) was tepid, dragged down by volatile streams, with core fee income posting healthy growth (+18% YoY). Valuation and view:we expect RoA to increase to ~2% in medium term on the back of market share gains, fee income growth, and maturing investments in branch network. Focus on rural and digital initiatives would also bear meaningful dividends. HDFCB remains an enviable franchise and will continue to demand valuation premium. It is amongst our top picks in the sector.at CMP of Rs 1,092 the stock trades at 3.3x/2.8x FY17E/FY18E ABV of Rs330/Rs387. We roll forward our estimates to FY18, valuing HDFCB at 3.6x FY18 P/ABV to arrive at TP of Rs 1,400 (28% upside from CMP). Financial summary (Standalone) PAT (Rs bn) 102 123 146 177 EPS (Rs) 41 49 58 70 EPS chg 15.3 19.3 18.8 21.4 Book value (Rs) 247 287 334 391 Adj. BV (Rs) 245 284 330 387 PE (x) 26.8 22.5 18.9 15.6 P/ABV (x) 4.5 3.8 3.3 2.8 RoE 19.4 18.3 18.6 19.4 RoA 1.9 1.9 1.9 1.9 Net NPA 0.2 0.3 0.3 0.2 Key drivers Q2FY16 Q3FY16 Q4FY16 Loan growth (YoY) 28 26 27 NIM 4.2 4.3 4.3 CASA 40 40 43 GNPA ratio 0.9 1.0 0.9 Price performance 120 100 Sensex HDFC Bank 80 60 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16 01

Q4FY16 results highlights Loan growth well above industry: Growth in Advances (+27% YoY) to Rs4.65tn was driven equally by retail loans (up ~30% YoY) and wholesale loans (up 27.2% YoY). Growth in retail advances was across the board, with each subsegment growing at a pace significantly above the system. The bank is constantly gaining market share, and we expect this trend to continue.we expect HDFCB to report CAGR loan growth of 24% over FY16-18. Exhibit 1: Market share of system advances & deposits 7 6 5 4 4.3 4.2 Advances 5.1 4.6 4.4 Deposits 4.8 5.4 5.1 6.3 5.6 We believe HDFCB will continue growing above the industry, and gain market share We expect HDFCB to report CAGR loan growth of 24% over FY16-18 3 FY12 FY13 FY14 FY15 FY16 LDR improves, CASAamongst best in class: LDR ratio increased to 85% (up ~160 bps QoQ) as Deposits (+21% YoY) grew a tad slower than advances. CASA ratio remained best in class at 43%, and was driven more by CA (up 20.2% YoY to Rs 0.9tn) than SA (up 18% YoY to Rs1.5tn). However, the sharp jump in CA deposits could be on account of seasonal trend. Exhibit 2: Trend in advances and deposits growth 35 Advances Growth Deposits Growth 30 25 23 25 23 30 30 28 27 26 27 20 15 19 21 22 22 21 21 17 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 NIM resilient at 4.3%:Despite declining yields (base rate cut at the beginning of the quarter), NIM stood its ground at 4.3% and was set off by decline in cost of deposits. We foresee headwinds to margins from MCLR regime and increased competition, though the impact would be marginal. The management is confident of maintaining the margins in the range of 4-4.4% 02

Healthy pick-up in core fee income:non-interest income growth (+13% YoY) howeverwas tepid, dragged down by volatile streams. Nonetheless, core fee income posted healthy growth (+18% YoY) well-supported by volume increase in insurance and mutual fund units Healthy asset quality:asset quality remained pristine and improved moderately, as GNPAs declined to 0.94% while NNPAs came in flat at 0.28% (0.29% in Q3FY16).Slippages were at Rs 17 bn (1.5%) and ~Rs 3.0 bn of floating provisions were drawn down to provide against agri-credit facility lent to Punjab and a large corporate account. O/s restructured loans remained stable at 0.1% of advances. 24 APR 2016 Quarterly Update Pick-up in loangrowth will push fee income up in medium term Exhibit 3: Trend in headline asset quality numbers GNPA NNPA PCR (RHS) 1.2 1.0 0.8 0.9 1.0 0.9 1.0 0.9 75 73 0.6 71 0.4 0.2 0.2 0.3 0.3 0.3 0.3 69 0.0 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 67 Aggressively expanding footprint: The bank continued adding branches (239 in 4Q; 506 for FY16) while maintaining cost-to-income ratio. Exhibit 4: Rapid branch expansion but with controlled costs 5,000 Existing Branches Additions Cost to Income (RHS) 4,500 506 4,000 3,500 50 50 611 3,000 341 518 2,500 46 558 2,000 45 44 1,500 1,000 FY12 FY13 FY14 FY15 FY16 52 50 48 46 44 42 40 We believe expanding branch network and focus on rural and digital presence will provide rich dividends, as and when these investments mature 03

Exhibit 5: Results update 24 APR 2016 Quarterly Update Quarter ended 12 months ended (Rs mn) Mar-16 Mar-15 % Chg Dec-15 % Chg Mar-17E Mar-16 % Chg Interest income 159,968 130,064 23 154,111 4 728,153 602,215 21 Interest expended 85,434 69,932 22 83,426 2 394,065 326,299 21 Net interest income 74,533 60,132 24 70,685 5 334,088 275,915 21 Non-interest income 28,659 25,638 12 28,722 (0) 127,288 107,517 18 Net income 103,192 85,769 20 99,407 4 461,376 383,432 20 Operating expenses 45,843 38,550 19 42,048 9 204,640 169,797 21 Operating profit 57,349 47,220 21 57,359 (0) 256,736 213,636 20 Provision & Contingencies 6,625 5,767 15 6,539 1 36,154 27,256 33 PBT 50,725 41,453 22 50,820 (0) 220,582 186,379 18 Tax 16,982 13,384 27 17,251 (2) 74,557 63,417 18 Net profit 33,742 28,069 20 33,568 1 146,025 122,962 19 Yields & Margins Yield on advances 10.6 11.0 (0.4) 10.7 (0.1) 10.6 10.8 (0.2) Cost of funds 5.8 5.9 (0.1) 5.8 (0.1) 5.9 6.0 (0.1) Net interest margin 4.3 4.4 (10) bps 4.3 0 bps 4.5 4.6 (4)bps Cost to income ratio 44.4 44.9 (52) bps 42.3 213 bps 44.4 44.3 7 bps Asset quality Gross NPAs (Rs bn) 43.9 34.4 27.8 42.6 3.2 54.5 43.9 24.0 Gross NPAs 0.9 0.9 1 bps 1.0 (3) bps 0.9 0.9 (1) bps Net NPAs (Rs bn) 13.2 9.0 47.3 12.6 4.7 15.2 13.2 15.5 Net NPAs 0.3 0.2 8 bps 0.3 (1) bps 0.3 0.3 (2) bps Provisioning coverage 69.9 73.9 (399) bps 70.4 (43) bps 72.0 69.9 206 bps Capital Tier-I 13.2 13.7 (50) bps 13.2 0 bps 12.2 13.2 (103) bps CAR 15.5 16.8 (130) bps 15.9 (40) bps 15.0 15.5 (55) bps Balance sheet (Rs bn) Advances 4,646 3,655 27 4,370 6.3 5,807 4,646 25.0 Deposits 5,464 4,508 21 5,240 4.3 6,725 5,464 23.1 CASA 43.2 44.0 (78) bps 40.0 327 bps 41.9 43.2 (135) bps Note: Full year ratios are on calculated basis 04

Financial summary (Standalone) Profit & loss (Rsbn) Interest earned 485 602 728 875 Interest expended (261) (326) (394) (476) Net interest income 224 276 334 399 Non interest income 90 108 127 150 Net income 314 383 461 548 Operating expenses (140) (170) (205) (238) Staff expenses (48) (57) (69) (76) Other operating expenses (92) (113) (136) (161) Operating profit 174 214 257 311 Provisions & contingencies (21) (27) (36) (44) Pre-tax profit 153 186 221 267 Tax expense (51) (63) (75) (90) Profit after tax 102 123 146 177 Extraordinary item - - - - Minority interest/associates - - - - Adj. PAT 102 123 146 177 Balance sheet (Rsbn) Total assets 5,905 7,088 8,685 10,468 Cash & Balances with RBI 363 389 479 555 Investments 1,516 1,639 1,939 2,262 Advances 3,655 4,646 5,807 7,141 Fixed assets 31 33 35 37 Other assets 339 381 425 474 Total liabilities 5,905 7,088 8,685 10,468 Equity capital 5 5 5 5 Preference capital - - - - Reserves & surplus 615 722 838 984 Networth 620 727 843 990 Borrowings 452 530 636 735 Deposits 4,508 5,464 6,725 8,147 Other liabilities & prov. 325 367 480 597 Key ratios Per share data FDEPS (Rs.) 41 49 58 70 BV (Rs.) 247 287 334 391 Adj. BV (Rs.) 245 284 330 387 DPS (Rs.) 8 10 10 11 Dividend payout 20 20 17 15 Yields & Margins Yield on advances 11.1 10.8 10.6 10.4 Cost of deposit 5.7 5.8 5.8 5.7 Net interest margin 4.4 4.6 4.5 4.4 Asset quality Gross NPAs 0.9 0.9 0.9 0.9 Net NPAs 0.2 0.3 0.3 0.2 Credit cost 0.6 0.6 0.7 0.6 Provisioning coverage 73.9 69.9 72.0 74.0 Capital Tier-I 13.7 13.2 12.2 11.3 CAR 16.8 15.5 15.0 13.7 Efficiency ROA 1.9 1.9 1.9 1.9 ROE 19.4 18.3 18.6 19.4 Cost to income 45 44 44 43 CASA 44 43 42 40 Effective tax rate 33 34 34 34 Growth Net interest income 21 23 21 19 Fee income 7 18 18 18 Operating expenses 16 21 21 16 Profit after tax 20 20 19 21 Advances 21 27 25 23 Deposits 23 21 23 21 Total assets 20 20 23 21 05

Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com. 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-month period. Research Team Sr. No Name Designation E-mail 1 Sunil Shah Head of Research sunil.shah@axissecurities.in 2 PankajBobade Research Analyst pankaj.bobade@axissecurities.in 3 Priyakant Dave Research Analyst priyakant.dave@axissecurities.in 4 Akhand Singh Research Analyst akhand.singh@axissecurities.in 5 BuntyChawla Research Analyst bunty.chawla@axissecurities.in 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report. 06

Disclaimer: Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai- 400070, Tel No. 18002100808/022-61480808, Regd. off.- Axis House, 8th Floor, Wadia International Centre, PandurangBudhkarMarg, Worli, Mumbai 400 025. Compliance Officer: AnandShaha, Email: compliance.officer@axisdirect.in, Tel No: 022-42671582. 07